Published in BMC Gastroenterol on November 09, 2013
Effect of one year of a gluten-free diet on the clinical evolution of irritable bowel syndrome plus fibromyalgia in patients with associated lymphocytic enteritis: a case-control study. Arthritis Res Ther (2014) 0.88
An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms. Rheumatol Int (2014) 0.82
Response to 'Remarkable prevalence of celiac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study' - authors' reply. Arthritis Res Ther (2014) 0.75
[Complementary and alternative procedures for fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles]. Schmerz (2017) 0.75
Celiac symptoms in patients with fibromyalgia: a cross-sectional study. Rheumatol Int (2014) 0.75
Fibromyalgia: Treating Pain in the Juvenile Patient. Paediatr Drugs (2017) 0.75
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum (1990) 27.50
Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology (1992) 10.44
A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health (1990) 8.18
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med (2003) 7.80
The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol (1999) 6.27
Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet (2001) 5.56
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology (2002) 4.40
Rome III: New standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis (2006) 3.10
The humoral response in the pathogenesis of gluten ataxia. Neurology (2002) 2.84
[Population reference values of the Spanish version of the Health Questionnaire SF-36]. Med Clin (Barc) (1998) 2.20
Clinical practice. Irritable bowel syndrome. N Engl J Med (2008) 1.89
The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol (2004) 1.85
In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut (2004) 1.79
Functional bowel symptoms, fibromyalgia and fatigue: a food-induced triad? Scand J Gastroenterol (2012) 1.70
A comparison of seven-point and visual analogue scales. Data from a randomized trial. Control Clin Trials (1990) 1.70
Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gastroenterol (1999) 1.61
The visual analogue scale: its use in pain measurement. Rheumatol Int (1985) 1.60
Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med (2009) 1.53
Epidemiology of fibromyalgia. Curr Pain Headache Rep (2003) 1.50
Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology (2004) 1.49
Celiac disease. World J Gastroenterol (2006) 1.44
Presentations of adult celiac disease in a nationwide patient support group. Dig Dis Sci (2003) 1.41
Spanish version of the Health Assessment Questionnaire: reliability, validity and transcultural equivalency. Grupo para la Adaptación del HAQ a la Población Española. J Rheumatol (1993) 1.40
Irritable bowel syndrome. Intern Med J (2006) 1.24
Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol (2006) 1.21
Fibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome. Pain Physician (2011) 1.16
The prevalence of fibromyalgia in other chronic pain conditions. Pain Res Treat (2011) 1.04
Fibromyalgia in patients with irritable bowel syndrome. An association with the severity of the intestinal disorder. Int J Colorectal Dis (2001) 0.99
Fibromyalgia: the gastrointestinal link. Curr Pain Headache Rep (2004) 0.95
[Frequency of celiac disease and irritable bowel syndrome coexistance and its influence on the disease course]. Przegl Lek (2009) 0.89
In the clinic. Celiac disease. Ann Intern Med (2011) 0.86
Prevalence of asymptomatic celiac disease in children with fibromyalgia: a pilot study. Pediatr Rheumatol Online J (2011) 0.84
Do published guidelines for evaluation of irritable bowel syndrome reflect practice? BMC Gastroenterol (2001) 0.83
Oral findings in coeliac disease and Sjögren's syndrome. Oral Dis (2004) 0.80
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry (2011) 5.46
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet (2010) 4.96
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA (2012) 3.85
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut (2013) 2.86
Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry (2011) 2.75
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet (2013) 2.39
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet (2009) 2.13
Prevalence of pathological internet use among adolescents in Europe: demographic and social factors. Addiction (2012) 2.01
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev (2011) 1.99
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res (2010) 1.90
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet (2013) 1.88
Life-time prevalence and psychosocial correlates of adolescent direct self-injurious behavior: a comparative study of findings in 11 European countries. J Child Psychol Psychiatry (2013) 1.85
Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study. Arthritis Res Ther (2013) 1.81
Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res (2006) 1.77
Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry (2013) 1.75
Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families. Breast Cancer Res Treat (2008) 1.72
Evaluation of the Two-Way Communication Checklist as a clinical intervention. Results of a multinational, randomised controlled trial. Br J Psychiatry (2004) 1.61
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS Genet (2010) 1.56
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet (2011) 1.51
Concordance of standard and modified NCEP ATP III criteria for identification of metabolic syndrome in outpatients with schizophrenia treated with antipsychotics: a corollary from the CLAMORS study. Schizophr Res (2007) 1.47
The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis. Gut (2010) 1.45
Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening. COPD (2006) 1.43
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Clin Cancer Res (2008) 1.43
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2010) 1.41
[Diagnostic value of E-cadherin, MMP-9, activated MMP-13 and anti-p53 antibodies in squamous cell carcinomas of head and neck]. Med Clin (Barc) (2007) 1.41
[PI*S and PI*Z alpha 1-antitrypsin deficiency: estimated prevalence and number of deficient subjects in Spain]. Med Clin (Barc) (2004) 1.40
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Res (2012) 1.38
Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes. Eur J Hum Genet (2012) 1.33
Posttraumatic growth in cancer: reality or illusion? Clin Psychol Rev (2008) 1.25
Adolescent subthreshold-depression and anxiety: psychopathology, functional impairment and increased suicide risk. J Child Psychol Psychiatry (2013) 1.24
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res (2011) 1.22
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2012) 1.17
The prevalence of metabolic syndrome in patients with bipolar disorder. J Affect Disord (2007) 1.13
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol (2011) 1.12
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10
Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study. Int J Neuropsychopharmacol (2009) 1.05
Remission in schizophrenia: results from a 1-year follow-up observational study. Schizophr Res (2009) 1.05
Novel methylation panel for the early detection of colorectal tumors in stool DNA. Clin Colorectal Cancer (2010) 1.02
MLH1 founder mutations with moderate penetrance in Spanish Lynch syndrome families. Cancer Res (2010) 1.01
Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH. Hum Mutat (2011) 1.01
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PLoS One (2010) 1.01
A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: findings from the CLAMORS study. Schizophr Res (2008) 1.01
Pathological Internet use among European adolescents: psychopathology and self-destructive behaviours. Eur Child Adolesc Psychiatry (2014) 1.00
Genome-wide linkage scan reveals three putative breast-cancer-susceptibility loci. Am J Hum Genet (2009) 0.99
Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study. Eur Psychiatry (2007) 0.99
Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Clin Rheumatol (2010) 0.97
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat (2009) 0.97
Refining the role of PMS2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants. J Med Genet (2013) 0.96
Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds. J Med Genet (2009) 0.96
Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis. Hum Mol Genet (2004) 0.95
Prevalence of α1-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review. Ther Adv Respir Dis (2012) 0.94
MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study. Eur J Hum Genet (2012) 0.94
A 25-year follow-up of patients admitted to methadone treatment for the first time: mortality and gender differences. Addict Behav (2011) 0.93
Allele-specific expression of APC in adenomatous polyposis families. Gastroenterology (2010) 0.93
The saving and empowering young lives in Europe (SEYLE) randomized controlled trial (RCT): methodological issues and participant characteristics. BMC Public Health (2013) 0.92
Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer. Breast Cancer Res Treat (2006) 0.92
Topiramate for the treatment of alcohol dependence: comparison with naltrexone. Eur Addict Res (2010) 0.92
Hereditary familial polyposis and Gardner's syndrome: contribution of the odonto-stomatology examination in its diagnosis and a case description. Med Oral Patol Oral Cir Bucal (2005) 0.92
Identification and comprehensive characterization of large genomic rearrangements in the BRCA1 and BRCA2 genes. Breast Cancer Res Treat (2009) 0.92
Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations. Hum Mutat (2009) 0.91
International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation. Breast Cancer Res Treat (2010) 0.91
Ethnic differences in alpha-1 antitrypsin deficiency in the United States of America. Ther Adv Respir Dis (2010) 0.90
Founder mutation in familial adenomatous polyposis (FAP) in the Balearic Islands. Cancer Genet Cytogenet (2005) 0.90
Differential role of serotonergic polymorphisms in alcohol and heroin dependence. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.90
Detection of genetic alterations in hereditary colorectal cancer screening. Mutat Res (2009) 0.90
Cardiovascular risk in patients with bipolar disorder. J Affect Disord (2008) 0.89
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res (2014) 0.89
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2012) 0.89
Conventional renal cancer in a patient with fumarate hydratase mutation. Hum Pathol (2007) 0.89
Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack? Br J Clin Pharmacol (2014) 0.89
[Guidelines for the diagnosis and management of alpha-1 antitrypsin deficiency]. Arch Bronconeumol (2006) 0.89
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Hum Mol Genet (2011) 0.89
No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome. Fam Cancer (2010) 0.89
Assessing the RNA effect of 26 DNA variants in the BRCA1 and BRCA2 genes. Breast Cancer Res Treat (2011) 0.89
Comprehensive functional assessment of MLH1 variants of unknown significance. Hum Mutat (2012) 0.89
Effect of one year of a gluten-free diet on the clinical evolution of irritable bowel syndrome plus fibromyalgia in patients with associated lymphocytic enteritis: a case-control study. Arthritis Res Ther (2014) 0.88
Usefulness of epithelial cell adhesion molecule expression in the algorithmic approach to Lynch syndrome identification. Hum Pathol (2012) 0.88
High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran. Hepatol Res (2005) 0.88
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Hum Genet (2011) 0.87
In vitro antisense therapeutics for a deep intronic mutation causing Neurofibromatosis type 2. Eur J Hum Genet (2012) 0.87
Risk-behaviour screening for identifying adolescents with mental health problems in Europe. Eur Child Adolesc Psychiatry (2013) 0.87
Transcriptional characteristics of familial non-BRCA1/BRCA2 breast tumors. Int J Cancer (2010) 0.87
Using topiramate or naltrexone for the treatment of alcohol-dependent patients. Alcohol Clin Exp Res (2008) 0.86
Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families. BMC Cancer (2012) 0.86
Functional characterization of the novel APC N1026S variant associated with attenuated familial adenomatous polyposis. Gastroenterology (2007) 0.86
Functional impairment as a defining feature of: amnestic MCI cognitive, emotional, and demographic correlates. Int Psychogeriatr (2012) 0.86
Is attempted suicide different in adolescent and adults? Psychiatry Res (2007) 0.86
Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the CLAMORS study. Eur Neuropsychopharmacol (2011) 0.85
Is the biological nature of depressive symptoms in borderline patients without concomitant Axis I pathology idiosyncratic? Sleep EEG comparison with recurrent brief, major depression and control subjects. Psychiatry Res (2004) 0.85
Psychometric properties of the Revised Physical and Social Anhedonia Scales in non-clinical young adults. Span J Psychol (2009) 0.85
Colorectal cancer risk and the APC D1822V variant. Int J Cancer (2004) 0.85
Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton depression rating scale (HAMD). J Affect Disord (2007) 0.85
Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid. Respir Res (2014) 0.85
MLH1 methylation screening is effective in identifying epimutation carriers. Eur J Hum Genet (2012) 0.85
[Psychometric performance of the 6th version of the Addiction Severity Index in Spanish (ASI-6)]. Psicothema (2010) 0.85